DOCSLIB.ORG

Life Sciences and Healthcare

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Life Sciences and Healthcare LIFE SCIENCES AND HEALTHCARE INTRODUCTION India’s healthcare industry is worth around According to a recent study by PA Consulting for UK Trade & Investment, £25−30 billion and is expected to grow to the Indian healthcare sector has been growing at a CAGR of 14%. over £40 billion in the next two–three years. There is a huge demand−supply mismatch. 73.77 It is estimated that over 80,000 multi- speciality and super-speciality hospital beds are required. The UK businesses specialising 63.33 in the pharmaceutical, advanced healthcare delivery, diagnostics and medical equipment 53.6 and insurance segments have been successful in India. Other than expanding 44.21 opportunities in these segments, there 40.76 are opportunities in e-healthcare, clinical 38.14 research, R&D, education and training. 34.84 30.25 According to a study by an industry body and Ernst & Young, India will require another LIfe ScIenceS and 1.75 million beds by the end of 2025. The HeaLtHcaRe cOntact: public sector, however, is likely to contribute only around 15−20% of the required $86 Prasenjit Dhar, billion (approx. £53.75 billion) investment. [email protected] Corporate India is therefore leveraging this Tel: + 44(0)20 7592 3040 business potential and various healthcare 2005 2006 2007 2008 2009 2010 2011 2012 www.ukibc.com brands have started aggressive expansion in the country. Ranbaxy, Dabur, Apollo (est) (est) (est) (est) Hospitals, Fortis, Cipla and Wockhardt Source: PA Consulting study. are already household names and others planning to increase their footprint, According to a recent study including Anil Ambani’s Reliance Health, by PA Consulting for UK Trade the Hindujas, the Sahara Group, Emami, & Investment, the Indian Apollo Tyres and the Panacea Group. India’s healthcare industry is worth around £25−30 billion and is healthcare sector has been expected to grow to over £40 billion in the next two–three years. growing at a CAGR of 14%. +44(0)20 7592 3040 www.ukibc.com LIFE SCIENCES AND HEALTHCARE The rural healthcare sector is also expanding. The UK has a long history of working to help UKIBc annUaL SUMMIt 2011 The session participants were: The Rural Health Survey Report 2009, meet patient needs in India. Recent years At our annual summit, which took place • Sir Mark Walport, Director, released by the Ministry of Health, stated have seen an increase in the number of UK on 10th March in Manchester, we had a The Wellcome Trust that during the last ive years the rural health providers who can support healthcare projects session focusing speciically on opportunities sector has added around 15,000 health sub- in India, either by having operations in India and challenges facing the healthcare and • Dr Brian Tempest, Chairman, Religare centres and 28,000 nurses and midwives. or by having established partnerships with life sciences sector. The session considered Capital Markets (ex-Director, Ranbaxy) The report further stated that the number Indian irms to deliver cost-effective solutions. areas such as affordable healthcare • Jamila Joseph, Head of Clinical Research of primary health centres have increased Some of the key UK players already present technologies, biotech, and technology Services, Reliance Life Sciences by 84%, taking the number to 20,107. in the Indian market are GlaxoSmithKline collaboration and transfers suitable for the and AstraZeneca, as well niche companies • Dr Pawan Saharan, Founder According to an IBEF report, the key growth Indian market. Other than giving an overview such as Smith & Nephew, Huntleigh, the and CEO, Biomix driver for the Indian healthcare market is of opportunities that the Indian market Smiths Group, Randox Laboratories, Omega the increased spending on healthcare by presents, the experts on the panel talked of Diagnostics and Touch Bionics. We are also • Chris Francis, Founder, Cardionetics the growing middle class. It is expected their experience of and plans for working increasingly seeing investment in the UK that healthcare expenditure will grow at in Indian and UK markets and answered • Sujay Shetty, Partner, Head of and other global markets from major Indian around 15% annually. The sector is likely questions about doing business in India. Pharmaceutical Group, PwC India life science companies such as Reliance to contribute over 6% of India’s GDP and Life Sciences and TCG Life Sciences. employ around nine million people by 2012. The Rural Health Survey Report 2009, released by the Ministry of Health, stated that during the last ive years the rural health sector has added around 15,000 health sub-centres and 28,000 nurses and midwives. Source: Ernst and Young Research +44(0)20 7592 3040 www.ukibc.com LIFE SCIENCES AND HEALTHCARE Based on these arguments, the health up supplies as they battle falling prices (FTA) negotiations, India may have to MARKET UPDATE ministry advocates doing away with the and increasing generic competition. abide by a series of international standards current automatic 100% FDI approval route and regulatory practices in the healthcare for the pharmaceutical industry, suggesting Cipla, with a market value of $5.5 sector. For instance, EU negotiators have IndIan PHaRMaceUtIcaL SectOR that foreign investment in that sector should billion, is one of the world’s biggest sought India’s commitment to adopting GROWS at 16.5% In 2010 be allowed through the more controlled producers of low-cost antiretroviral Global Harmonisation Task Force (GHTF) and case-by-case FIPB (Foreign Investment norms for medical devices. The move The Indian pharmaceutical sector continued drugs to ight HIV and AIDS. its strong showing in 2010, growing at Promotion Board) route. However, at an comes at a time when India and other 16.5%. The £6.4 billion pharma market inter-ministerial meeting, the Finance Ministry Asian countries are trying to formulate has been on an upswing over the last four opposed changes to the current FDI policy for their own harmonised regulatory guidelines years, with annual growth of 13−17%, the pharma sector. Meanwhile, Commerce VIIV HeaLtHcaRe SeeKS PaRtneRS for medical devices because of divergent buoyed by strong demand, improved and Industry Minister Anand Sharma said fOR HIV dRUG In IndIa views on some of the GHTF standards. that FDI in new pharma projects would spending on healthcare and rising middle- In yet another attempt to drive down costs, India is also trying to align its rules with the continue and only those Indian companies class incomes. Industry experts expect the global drug maker ViiV Healthcare (a joint International Conference on Harmonisation that receive government funds for research trend to continue, with market growth for venture that houses the HIV/AIDS drugs (ICH) guidelines for drug regulators, , though could face a curtailment of their funding. 2011 forecast in the range of 15−17%. business of GlaxoSmithKline Pharmaceuticals not favouring simple adoption. Indian industry and Pizer, Inc.) is evaluating the scope sources say strict adherence to ICH guidelines MInIStRIeS deBate fdI In cIPLa In taLKS WItH GSK tO of local partnerships in India. One of the will help big pharmaceutical companies, but SUPPLY dRUGS potential organisations is Natco Pharma, prove to be a barrier for the growth of smaller PHaRMaceUtIcaLS which has sought a voluntary licence to make ones owing to the cost involved in such trials. Indian drug maker Cipla Ltd is said to be In pharmaceuticals, 100% foreign direct a low-cost version of the drugs. According to in talks with drug companies including investment (FDI) is permitted but there Viiv Healthcare, the local partners could be GlaxoSmithKline and Israel’s Teva to has been a debate within the Indian either for manufacturing or for marketing. HeaLtH InSURance PORtaBILItY government, the Ministry of Health and supply generic drugs. Cipla, India’s IntROdUced In IndIa second-largest pharmaceutical company If the deal goes through, this could Family Welfare arguing that acquisition The Indian insurance sector regulator by market value, has been in negotiations ultimately lead to the irst case in which a of Indian pharmaceutical companies by (IRDA) has approved a proposal to allow with GlaxoSmithKline for a few months compulsory drug licence is imposed for the multinationals could orient them away customers to switch health insurance policies for a number of speciic products. Indian domestic market. The controversial from the Indian market, thus reducing to an insurer of their choice. Though this provision under which the Indian government the domestic availability and increasing Cipla, with a market value of $5.5 billion, move is expected to provide customers can allow a generic drug maker to make the prices of the drugs they produce. The is one of the world’s biggest producers with more choice, market experts feel that a low-cost version of a patented drug by ministry is also concerned that takeovers of low-cost antiretroviral drugs to ight it is unlikely to lead to a signiicant fall in paying a fee is opposed by foreign drug might skew the market structure, which HIV and AIDS. The company provides premium rates. With rising medical costs makers, but is allowed under local laws. means a clutch of companies dictating AIDS drugs to African companies for just and a high inlation rate, most health prices of drugs that are critical for dealing $350 per year per patient, compared with insurers are just covering costs on their with public health concerns, including $10,000 charged by multinationals. tOUGH neGOtIatIOnS OVeR health portfolio
Load more

Recommended publications
  • Download Full Report
    CONTENTS 02 Unstoppable Corporate overview We have been persistent 02 Unstoppable in our aim to establishing 04 Chairman’s Message and maintaining market leadership to be able to achieve 06 Vice Chairman’s Message unprecedented growth for our 08 Board of Directors stakeholders. 10 Management Board 12 Key Performance Highlights 14 14 Integrated Report Integrated Report 28 Management Discussion & Analysis Apollo Tyres’ contribution 51 Sustainability Snapshot to social and economic development is critical to create and sustain an enabling environment for investment. This has enabled the Company’s positioning as a credible Statutory Reports stakeholder partner. 84 Board’s Report 95 Annual Report on CSR 28 102 Business Responsibility Report Management 126 Corporate Governance Report Discussion & Analysis Financial Statements 161 Standalone Financial Statements 223 Consolidated Financial Statements UNSTOPPABLE Since inception, we have worked towards establishing ourselves as a leading player in the sale and manufacture of tyres. We have been persistent in our aim to establishing and maintaining market leadership and be able to achieve unprecedented growth for our stakeholders. In FY2018-19 (FY2019), we continued to focus We are unstoppable in establishing our on our key revenue generating regions APMEA leadership across multiple segments. (Asia Pacific, Middle East and Africa, including Our consistently advancing product range coupled India) and Europe. We expanded our presence in with product innovations are enabling us to achieve Americas by added new territories and increasing the same. our value proposition. The APMEA operation continued its focus on consolidating its leadership We are unstoppable in working towards achieving and enhancing share in India through the cutting edge manufacturing capabilities and introduction of best in class and technologically world-class R&D.
    [Show full text]
  • Consumer Goods Recovery in Discretionary and Urban Sales Led to Better Q3 Sector Update
    Consumer Goods Recovery in discretionary and urban sales led to better Q3 Sector Update Consumer goods companies’ Q3 performance was driven by sales recovery of Q3FY2021 Results Review discretionary categories (such as value-added hair oil and personal care products), sustained higher demand for healthcare and hygiene products, better traction to Sector: Consumer Goods new launches, and higher demand in rural markets coupled with improving demand in urban markets. General trade continues to grow strongly, e-commerce mix to Sector View: Positive overall revenue is improving due to higher sales and modern trade channel has witnessed sequential improvement due to recovery in urban sales. Most consumer goods companies under our coverage registered organic revenue growth of 6%-16%, driven by domestic volume growth of 7%-18% in Q3. Paint companies, including Asian Paints, registered strong volume growth of 30%, led by sustained high demand in tier III/IV towns and improving demand in metros and top cities due to receding scare of virus and improving construction and real estate activities. Overall, Sharekhan’s consumer goods universe registered revenue growth of ~14% in Q3FY2021, better than 9.1% growth achieved in Q2FY2021. Significant increase Our coverage universe in prices of palm oil, copra, other edible oils, and raw tea/coffee resulted in gross Companies CMP Reco. PT margin decline for companies such as HUL, Godrej Consumer Products (GCPL), (Rs) (Rs) Marico, and Tata Consumer Products (TCPL). However, lower ad spends and cost- Asian Paints 2,389 Buy 3,000 saving initiatives arrested the sharp decline of 80-100 bps in operating profit margins (OPM) for some companies.
    [Show full text]
  • Emami Companyname
    RESULT UPDATE EMAMI Health and rural focus to bear fruit India Equity Research| Consumer Goods COMPANYNAME Emami’s consolidated Q1FY21 revenue (down 25.8% YoY), EBITDA (down EDELWEISS 4D RATINGS 8.3% YoY) and PAT (up 1.2% YoY) were better than our estimates. The Absolute Rating BUY lockdown affected performance in April and May, but June (domestic Rating Relative to Sector Performer business up 8% YoY) turned out to be well. The recovery has sustained Risk Rating Relative to Sector High with double-digit growth in July. Soft mentha prices expanded gross Sector Relative to Market Underweight margin 231bps YoY; with mentha prices remaining benign, we expect gross margin expansion to sustain. A sharp cut in ad spends (down 749bps YoY) led to 487bps YoY EBITDA margin expansion. The lockdown MARKET DATA (R: EMAM.BO, B: HMN IN) affected international business (IB) as well overall sales dipped 18% YoY CMP : INR 257 Target Price : INR 296 (however up 7% YoY in June). Going ahead, with promoter-level pledging 52-week range (INR) : 358 / 131 concern alleviating in the wake of the recent Emami Cement sale, a slew Share in issue (mn) : 444.5 of launches in health & hygiene to capitalise on the topical upswing, and M cap (INR bn/USD mn) : 115 / 1,510 a higher rural contribution should hold the company in good stead. Avg. Daily Vol.BSE/NSE(‘000) : 958.1 Maintain ‘BUY’ with a TP of INR296. SHARE HOLDING PATTERN (%) Health & hygiene portfolio gains; discretionary portfolio suffers Current Q4FY20 Q3FY20 Key highlights: i) 43% of portfolio, which is aligned towards health & hygiene, grew Promoters * 53.9 52.7 52.7 29% YoY while the balance fell 44% YoY.
    [Show full text]
  • IN the BUSINESS of PROGRESS CONTENTS Apollo Tyres in Brief
    Annual Report 2019-20 IN THE BUSINESS OF PROGRESS CONTENTS Apollo Tyres in brief 01-03 Apollo Tyres is one of the most trusted Corporate factsheet names in the manufacture and sale of tyres. The Company was founded in 1972 and is 04-13 headquartered in Gurugram, Haryana (India). Leadership and governance 06 Chairman’s message 08 Vice-Chairman’s message 10 Board of Directors Catering to all tyre segments 12 Management Team TRUCK AND BUS LIGHT TRUCK 14-77 Performance and progress 16 Key performance indicators 18 Know our capitals 20 Business model 22 Capital-wise information 36 Progress amidst volatility 38 Progress that is sustainable 40 Progress through people centricity 42 Value created for the stakeholders PASSENGER VEHICLES TWO-WHEELER 78-93 Management Discussion & Analysis 94-170 Statutory Reports 94 Board’s Report 107 Annual Report on CSR 113 Business Responsibility Report 138 Corporate Governance Report OFF-HIGHWAY 171-305 Financial Statements 171 Standalone 233 Consolidated Apollo Tyres’ success as a leading tyre such as: geo-political relations, economic manufacturer is inextricably linked with the growth, industry cyclicality, environmental progress of the people, the businesses we issues, technological innovation, safety and partner and the planet at large. We have consumer attitudes. Our FY20 performance is always persevered to exceed expectations, a reflection of the resulting uncertainties. It set new benchmarks and in some cases, is also a testament to our foundational values shape the future of the industry. and intrinsic strengths that have helped us navigate through these uncertainties. Our marquee brands, Apollo and Vredestein, enjoy premium positions in the commercial As we step into a new decade, replete with and passenger vehicle tyre segments in unexplored opportunities, we are keen on India and Europe, respectively.
    [Show full text]
  • HSBC Saudi Arabia Limited
    HSBC Saudi Arabia Limited HSBC China & India Equity Freestyle Fund - IAF Fund Details Monthly Factsheet Fund Manager HSBC Saudi Arabia Ltd. as of 31 January 2015 Inception Date 12 December 2005 Profile Inception Price USD 10 To provide capital appreciation through investing in a well-diversified portfolio comprising of shares in Indian and Chinese companies over a long period of five years and above . Fund Type Open ended Top Holdings Investment Policy Freestyle Management Stock Weight % Base Currency US Dollar of the Fund Tencent Holdings Ltd. 10 Baidu Inc. Sponsored ADR 9 Risk/Return Profile High Infosys Ltd. 8 Bloomberg Code SABCHIN AB Wipro Ltd. 7 Emami Ltd. 5 Zawya Code HSBCIEF.MF Oil & Natural Gas Corp. Ltd. 4 Fund Size (USD) 44 Million HCL Technologies Ltd. 4 Minimum Initial USD 2,000 Maruti Suzuki India Ltd. 4 Investment Cognizant Tech Solutions 4 Glenmark Pharmaceuticals Ltd. 4 Minimum Additional USD 1,000 Investment Fund Composition Valuation Day Monday & Thursday Cut off Time Before close of business; On Sunday for Monday valuation, and on Wednesday for Thursday valuation. Redeemed Funds Four business days Payment after valuation day Annual Management Fee 2% Subscription Fee Up to 2% Contact Details HSBC Saudi Arabia Limited Local Investors Toll Free Number 800 124 1212 International Investors Tel +966 1 299 2313 / +966 1 299 2314 Website www.hsbcsaudi.com Email: [email protected] Issued by HSBC Saudi Arabia Limited Authorized and regulated by Capital Market Authority License No. 05008-37 Please note that the above figures refer to past performance and that past performance is not a reliable indicator of future results.
    [Show full text]
  • Emami (HMN IN)
    Emami (HMN IN) Rating: BUY | CMP: Rs444 | TP: Rs526 December 2, 2020 Enters virtuous cycle of Seasonality; BUY Company Update Quick Pointers: Change in Estimates | ☑ Target | Reco . Early onset of winter has boosted demand for Winter care products Change in Estimates . Strong rural demand and Low base (3Q growth of 3.3% in past 5 years) augur Current Previous well for demand, base in 4Q21 and 1Q22 will be -19.7% and -25.8% FY22E FY23E FY22E FY23E Rating BUY BUY Target Price 526 450 . Most power brands are in good shape except F&H, we are cautious on new Sales (Rs. m) 31,293 34,585 31,293 34,585 launches despite encouraging initial response % Chng. - - EBITDA (Rs. m) 9,299 9,988 9,299 9,988 % Chng. - - We are upgrading target price of Emami to Rs526 (Rs450 earlier) as we EPS (Rs.) 16.7 18.8 16.7 18.8 % Chng. - - increase PE multiple from 26 to 28x (last 5-year average 38.6x, 25% discount to coverage universe) and rollover valuations to FY23. We believe Emami has Key Financials - Standalone hit a sweet spot for growth led by 1) Strong rural demand as it is 55% of sales Y/e Mar FY20 FY21E FY22E FY23E for Emami 2) strong demand for winter care products on early onset of winter Sales (Rs. m) 26,549 27,780 31,293 34,585 3) low base for 3Q ( 5 year sales growth of 3.3%, 19.7% and 25.8% decline in EBITDA (Rs. m) 6,905 8,594 9,299 9,988 4Q and 1Q) 4) Kesh king has gained traction and is gaining share in premium Margin (%) 26.0 30.9 29.7 28.9 PAT (Rs.
    [Show full text]
  • Oman Chapter) an Open Access Journal DOI: 10.12816/0044909 Special Issue: PECTEAM 2018
    Arabian J Bus Manag Review (Oman Chapter) An Open Access Journal DOI: 10.12816/0044909 Special Issue: PECTEAM 2018 Arabian Journal of Business and Management Review (Oman Chapter) ResearchResearch Article Homepage: www.arabianjbmr.com AGJ A STUDY ON APPLICATION OF BRAND VALUATION TECHNIQUES WITH REFERENCE TO FAST MOVING CONSUMER GOODS COMPANIES Aisha Banu Research Scholar - Bangalore University Presidency College, Kempapura, Hebbal, Bangalore – 560 024 Dr. Lily David Research Supervisor, Bangalore University St.Joseph College of Commerce, Bangalore Dr. K R Pundareekavittala Co-Research Supervisor Presidency College, Kempapura, Hebbal, Bangalore -560024 Abstract Brand Valuation for the purpose of technical valuation results In balance sheet reporting, tax planning, mergers and acquisitions and investor relations purpose. Though there are various brand valuation techniques available, none can be applied in order to arrive at more accurate value of brand. In light of this drawback, this research paper has been taken up to derive an appropriate brand valuation technique or model suitable to Fast Moving Consumer Goods Companies. The researcher has gathered top ten companies from FMCG based on market capitalisation. Their four years annual reports are analysed, using statistical techniques to substantiate the model arrived at. Introduction Brand refers to any name, design, symbol or any other feature that differentiates one product from another. It is intangible which includes trade names, trademarks, trade symbols, domain names, design rights, trade dress, packaging, copyrights, associated goodwill and advertising visuals. Brand is an intangible asset and very important to a wide variety of industries. The relative importance of intangible asset like brand varies industry wise. For a Pharmaceutical industry, knowledge asset is important, in a Retailing industry Business process asset is significant, for an Airline industry market position asset is primary driver and thus goes the list for various industries.
    [Show full text]
  • Annexure to the Board Report | L&T Annual Report 2019-20
    Annexure ‘A’ to the Board Report and EnPI reduction of CG moulding energy consumption. Information as required to be given under Section 134(3) zz Implemented Smart COMM Energy Management (m) read with Rule 8(3) of the Companies (Accounts) system at ASW & Digital Dashboard. Rules, 2014. zz Replacement of conventional light fittings with [A] CONSERVATION OF ENERGY: Solar lighting system in SSII, Open yard-5 and (i) Steps taken or impact on conservation of Grit blasting & painting areas at Production/ energy: Utility areas at EWL Kancheepuram factory and Kansbahal works. zz Implementation of LED lights in HE-Hazira campus and other project sites and Solar Pipes in zz Replacement of conventional MH Lamps and SG fabrication area. fluorescent tube lights by LED lamps in working areas at office and projects as well as for street zz Installation of an Off Grid Mini-Solar Power Plant for meeting the energy requirement of site & lights. workmen habitats at Ranchi Smart City Project. zz Installation of energy efficient water coolers and submersible pumps zz Installed Local Pre/ Post Weld Heat Treatment (PWHT) using PID Technology which ensures zz Replacing existing aged inefficient Split AC units uniform heating and reduction in energy with energy efficient units wastage. zz Utilization of Chiller for HVAC System – Campus zz Implemented the use of Metal Halide (400 Watt) FMD initiated and control the chiller running EOT Crane under bay lights with LED Lights. hour for HVAC need during holidays and extended working hours. zz Installed Energy efficient burners for Furnaces and pre heating. zz Initiative has been taken for replacement of Air-Cooled Chiller with Water Cooled Chiller.
    [Show full text]
  • 20130118104321Small366.Pdf
    Contents PERFORMANCE REPORT 2006-7 Forward looking statement In this Annual Report we have disclosed forward-looking information to enable investors to comprehend our prospects and take informed investment decisions. This report and other statements that we 10 periodically make contain forward-looking Yesterday’s statements that set out anticipated results wisdom, based on the management’s plans and tomorrow’s assumptions. We have tried wherever products possible to identify such statements by using words such as ‘anticipate’, Why does a nation of 1.1 billion ‘estimate’, ‘expects’, ‘projects’, ‘intends’, Cover story 30 consumers trust Emami? ‘plans’, ‘believes’, and words of similar substance in connection with any India’s FMCG success Wealth at discussion of future performance. story and Emami 18 the bottom of 26 Readers should bear in mind that we the pyramid cannot guarantee that these forward- looking statements will be realised, although we believe we have been prudent in our assumptions. The achievement of 12 results is subject to risks, uncertainties and The fame game: why brands estimates taken as assumptions. Should need celebrities known or unknown risks or uncertainties materialise, or should underlying Enhancing returns, Indian realty sector: assumptions prove inaccurate, actual 40 creating wealth 42 Gaining visibility results could vary materially from those anticipated, estimated or projected. 28 Emami and its global footprint 05 Inauguration of the new corporate office Also Opinions. Appreciation 02 Emami as a Group 46
    [Show full text]
  • Registered Msos As on 03.08.2020 S.No
    Registered MSOs as on 03.08.2020 S.No. Name of MSO Address for Correspondence State Type of Entity Registration No. Date of issue Registation Phone No. Email Remarks of Valid Registration Upto (DD/M M/YYYY) 1 5 Star Network Surpura Road, Bahel Haryana Proprietorship 9/240/2016-DAS 31-10-2016 30-10-2026 98122 45678 5starnetworkbehal@gmail. Bhiwani – 127028 com 2 9 Star Digital Cable D.No. 15-195, Karampudi Road, Andhra Pradesh Partnership 9/109/2015-DAS 24-06-2016 23-06-2026 98483 18777 Palnadu.communications@ Network Gurazala gmail.com Dist. Guntur – 522415 3 A B C O Plot No.6, Ashok Nagar , Odisha Partnership 9/97/2016-DAS 17-05-2016 16-05-2026 98614 44555 [email protected] Bhubaneswar Opp. State Bank of Hyderabad, District Khurda – 751009 4 A Boss Digital System Murugandha Bhavanam, Tamil Nadu Proprietorship 9/491/2015-DAS 17-05-2016 16-05-2026 98421 66931 [email protected] 14-C AA Road Madurai – 625016 5 A– Vision Channel Vrindavan Colony Chhattisgarh Proprietorship 9/77/2016-DAS 26-02-2016 25-02-2026 94252 58909 [email protected] Jagdalpur District m Bastar – 494001 6 A.C.N Cable Pvt. Ltd. Trade Center, No. 29/4, Karnataka Company 9/44/2013-BP&L 21-07-2015 20-07-2025 80428 84888 [email protected] 4th Floor, Race Course Road, 95380 67831 [email protected] Banglore – 560001 080 4288-4288 7 Aadhar Digital Vision Pvt. 37/19, Ayalur Muthiah Street, Tamil Nadu Company 9/56/2012-BP&L 21-02-2014 20-02-2024 98409 03060 [email protected] Ltd Kondithope, Chennai - 600079 94449 99763 [email protected] 8 Aadhishakti Digital Plot No.
    [Show full text]
  • Market Preview Domestic Indices Market Snapshot Global Indices
    24-DEC-2020 Domestic Indices Market wrap up Domestic indices Key domestic indices ended with strong gains on Wednesday, index Close Prv close %Chg supported by rally in IT stocks. The Nifty closed above the crucial NIFTY 50 13,601.1 13,466.3 1.00 NIFTY SMALLCAP 50 3425.5 3327.15 2.96 13,600 mark. All the sectoral indices on the NSE ended in the NIFTY MIDCAP 50 5,757.5 5,598.5 2.84 green. Positive global cues boosted sentiment.The BSE Sensex NIFTY SMALLCAP 250 5881.8 5718.9 2.85 rallied 437.49 points to 46,444.18. The Nifty 50 index added NIFTY BANK 29,883.3 29,626.0 0.87 134.80 points or 1% to 13,601.10.HUL, ITC and Reliance NIFTY NEXT 50 31949.8 31417.3 1.69 NIFTY METAL 3,134.1 3,079.7 1.77 Industries advanced.The broader market rallied. The BSE Mid- INDIA VIX 20.5 21.99 -6.77 Cap index rose 2.40% and the BSE Small-Cap index gained Global indices 2.65%.Buyers outpaced sellers. On the BSE, 2,296 shares rose and 650 shares fell. A total of 151 shares were unchanged. index Close Prv close %Chg Global Market NASDAQ 11,854.0 11,849.3 0.04% The S&P 500 closed barely in positive territory on Wednesday as DOW 28,323.4 28,391.4 -0.24% CAC 40 5,495.0 5,407.1 1.60% an expected stimulus deal and falling jobless claims prompted DAX 11,137.0 10,919.8 1.95% investors to put their money into sectors most likely to benefit NIKKEI 25,527.0 24,985.8 2.12% from the economy re-opening when it recovers from the global HANG SENG 26,016.2 25,709.2 1.18% health crisis.The Dow Jones Industrial Average rose 114.32 NYSE 2,072.2 2,077.2 -0.24% FTSE 1,524.3 1,519.6 0.31% points, or 0.38%, to 30,129.83, the S&P 500 gained 2.75 points, or 0.07%, to 3,690.01 and the Nasdaq Composite dropped 36.80 As on 8.00 IST points, or 0.29%, to 12,771.11.Asian shares were set to rise on NiftyMarket Watch Snapshot Thursday ahead of the Christmas break, as global investors cheered a potential Brexit deal and economic recovery prospects, largely ignoring U.S.
    [Show full text]
  • 20130118104629Small41.Pdf
    Crores of Indian households. A number of family members. Multiple needs. One choice. Joint promoters’ statement “A presence in every house, a recall in every mind – ‘ghar ghar mein Emami’ – has been our driving inspiration since inception” Joint promoters Shri R.S. Agarwal and Shri R.S. Goenka, highlight the Company’s direction and potential There are a number of numerical another year of our successful growth. Emami and growth parameters that one can use to Our performance improved While apparently it appears that 2007- demonstrate that we performed significantly as 2007-08 was a good 08 was tilted towards the industry, the creditably during the financial year year with our topline and bottomline fact remains that we confronted the 2007-08, but the one that stands the growing by 13% and 41% respectively. biggest challenges in terms of an test of industry, analysts and company We feel that there was a sustained unprecedented increase in the cost of is our performance compared with the growth in per capita income, riding on raw materials, a strong price- broad industry average. For instance, the ripple effect of India’s economic sensitivity across most product the broad FMCG industry in India grew growth which benefited a bigger categories, a greater need for wider at a CAGR of about 6% in the last concentration of households. As there and deeper distribution to reach three years; Emami grew at a CAGR was a perceptible increase in people’s customers and the ever-lingering of 25%. aspirations and purchasing power, our threat from counterfeit and This stellar performance sends multiple advertising and brand positioning unorganised products.
    [Show full text]